A Review of MAL-PDT for the Treatment Strategy of Actinic Keratosis: Broader Clinical Perspectives Beyond the Data and Guideline Recommendations

[1]  Y. Gilaberte,et al.  Fully home‐based methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face or scalp: A real life open study , 2022, Dermatologic therapy.

[2]  A. Wennberg,et al.  Cyclic photodynamic therapy delays first onset of actinic keratoses in renal transplant recipients: a 5‐year randomized controlled trial with 12‐month follow‐up , 2022, Journal of the European Academy of Dermatology and Venereology.

[3]  P. Papalexis,et al.  The Role and Effectiveness of Photodynamic Therapy on Patients With Actinic Keratosis: A Systematic Review and Meta-Analysis , 2022, Cureus.

[4]  G. Fabbrocini,et al.  New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma , 2022, Advances in Therapy.

[5]  S. Mordon,et al.  Clinical evaluation of a short illumination duration (1 hour) when performing photodynamic therapy of actinic keratosis using the Dermaris. , 2021, Photodiagnosis and photodynamic therapy.

[6]  M. Haedersdal,et al.  A 12-month follow-up split-scalp study comparing calcipotriol-assisted MAL-PDT with conventional MAL-PDT for the treatment of actinic keratosis: a randomized controlled trial , 2021, EJD. European journal of dermatology.

[7]  P. Calzavara-Pinton,et al.  A randomized split-face clinical trial of conventional vs indoor-daylight photodynamic therapy for the treatment of multiple actinic keratosis of the face and scalp and photoaging , 2021, The Journal of dermatological treatment.

[8]  R. Luiz,et al.  Comparison of clinical and histologic findings in daylight photodynamic therapy for skin field cancerization: a randomized controlled four-arm study on physical methods-assisted delivery of methyl aminolevulinate. , 2021, Photodiagnosis and photodynamic therapy.

[9]  A. Piccioni,et al.  SEQUENTIAL TREATMENT OF CALCITRIOL AND METHYL AMINOLEVULINATE-DAYLIGHT PHOTODYNAMIC THERAPY IN PATIENTS WITH MULTIPLE ACTINIC KERATOSES OF THE UPPER EXTREMITIES. , 2021, Photodiagnosis and photodynamic therapy.

[10]  M. Koller,et al.  Repetitive Daylight Photodynamic Therapy versus Cryosurgery for Prevention of Actinic Keratoses in Photodamaged Facial Skin: A Prospective, Randomized Controlled Multicentre Two-armed Study , 2020, Acta dermato-venereologica.

[11]  J. Utikal,et al.  Treatment Motivations and Expectations in Patients with Actinic Keratosis: A German-Wide Multicenter, Cross-Sectional Trial , 2020, Journal of clinical medicine.

[12]  C. Berking,et al.  S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma – short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality‐of‐care indicators , 2020, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[13]  Á. Juarranz,et al.  Influence of Serum Vitamin D Level in the Response of Actinic Keratosis to Photodynamic Therapy with Methylaminolevulinate , 2020, Journal of clinical medicine.

[14]  R. Sultana,et al.  Photodynamic therapy for the prevention and treatment of actinic keratosis/squamous cell carcinoma in solid organ transplant recipients: a systematic review and meta‐analysis , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[15]  P. Redondo,et al.  Daylight photodynamic therapy for prevention of new actinic keratosis and keratinocyte carcinomas in organ transplants. A cryotherapy‐controlled randomized clinical trial , 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

[16]  S. Karrer,et al.  European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications – actinic keratoses, Bowen's disease and basal cell carcinomas , 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

[17]  M. Fernández-Guarino,et al.  Split‐face study comparing conventional MAL photodynamic therapy in multiple actinic keratosis with complete time vs. half‐time red light LED conventional illumination , 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

[18]  S. Karrer,et al.  Methyl aminolevulinate daylight photodynamic therapy applied at home for non‐hyperkeratotic actinic keratosis of the face or scalp: an open, interventional study conducted in Germany , 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

[19]  Li Wang,et al.  Daylight versus conventional photodynamic therapy for the treatment of actinic keratosis: A meta-analysis of randomized controlled trials. , 2019, Photodiagnosis and photodynamic therapy.

[20]  C. Berking,et al.  Local interventions for actinic keratosis in organ transplant recipients: a systematic review , 2018, The British journal of dermatology.

[21]  M. Haedersdal,et al.  Efficacy and safety of daylight photodynamic therapy after tailored pretreatment with ablative fractional laser or microdermabrasion: a randomized, side‐by‐side, single‐blind trial in patients with actinic keratosis and large‐area field cancerization , 2018, The British journal of dermatology.

[22]  J. Szepietowski,et al.  Treatment of Actinic Keratosis with Photodynamic Therapy Using Red or Green Light: A Comparative Study. , 2018, Acta dermato-venereologica.

[23]  Rolf-Markus Szeimïes.  Pain perception during photodynamic therapy: why is daylight PDT with methyl aminolevulinate almost pain-free? A review on the underlying mechanisms, clinical reflections and resulting opportunities. , 2018, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[24]  Y. Gilaberte,et al.  Self-expressed patient preferences for the treatment of actinic keratosis: results from a non-interventional study based on a real-life setting in Spain , 2018, European Journal of Dermatology.

[25]  D. Rigopoulos,et al.  Conventional vs. daylight photodynamic therapy for patients with actinic keratosis on face and scalp: 12‐month follow‐up results of a randomized, intra‐individual comparative analysis , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

[26]  S. Ibbotson,et al.  Patient and physician satisfaction in an observational study with methyl aminolevulinate daylight photodynamic therapy in the treatment of multiple actinic keratoses of the face and scalp in six European countries , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[27]  N. Kerrouche,et al.  High Patient Satisfaction with Daylight-Activated Methyl Aminolevulinate Cream in the Treatment of Multiple Actinic Keratoses: Results of an Observational Study in Australia , 2017, Dermatology and Therapy.

[28]  Thomas Dirschka,et al.  Real-world approach to actinic keratosis management: practical treatment algorithm for office-based dermatology , 2017, The Journal of dermatological treatment.

[29]  K. Peris,et al.  Structured Expert Consensus on Actinic Keratosis: Treatment Algorithm Focusing on Daylight PDT , 2017, Journal of cutaneous medicine and surgery.

[30]  J. Groenewoud,et al.  Comparison of “Lesion-by-Lesion” and Field Photodynamic Therapy in the Prevention of Actinic Keratoses: A Randomized, Split-Face, Single-Blind Pilot Study , 2017, Dermatology.

[31]  H. Wulf,et al.  Pretreatment with 5-Fluorouracil Cream Enhances the Efficacy of Daylight-mediated Photodynamic Therapy for Actinic Keratosis. , 2017, Acta dermato-venereologica.

[32]  J. McCavana,et al.  Artificial White Light vs Daylight Photodynamic Therapy for Actinic Keratoses: A Randomized Clinical Trial. , 2016, JAMA dermatology.

[33]  B. Dréno,et al.  Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator‐blinded, controlled, phase III study throughout Europe , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[34]  S. Shumack,et al.  Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia , 2015, The Australasian journal of dermatology.

[35]  Praven Chetty,et al.  Primary Care Review of Actinic Keratosis and Its Therapeutic Options: A Global Perspective , 2015, Dermatology and Therapy.

[36]  H. Wulf,et al.  Combination of ablative fractional laser and daylight‐mediated photodynamic therapy for actinic keratosis in organ transplant recipients – a randomized controlled trial , 2015, The British journal of dermatology.

[37]  S. Shumack,et al.  Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial , 2014, The British journal of dermatology.

[38]  R. Botella-Estrada,et al.  A randomized pilot comparative study of topical methyl aminolevulinate photodynamic therapy versus imiquimod 5% versus sequential application of both therapies in immunocompetent patients with actinic keratosis: clinical and histologic outcomes. , 2012, Journal of the American Academy of Dermatology.

[39]  B. L. Andersen,et al.  A randomized, multicentre study of directed daylight exposure times of 1½ vs. 2½ h in daylight‐mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp , 2011, The British journal of dermatology.

[40]  K. Peris,et al.  Long-term efficacy and safety of daylight photodynamic therapy with methyl aminolevulinate for actinic keratosis of the face and scalp , 2017, EJD. European journal of dermatology.